Modulation of murine osteoarthritis

Area of Science:

• Biomedical research
• Orthopedics
• Pharmacology

Background:

• Male STR/ORT mice exhibit a high incidence of early-onset osteoarthritis (OA), particularly in the medial tibial cartilage.
• OA development in these mice is associated with altered monoamine oxidase (MAO) activity, impacting catecholamine metabolism.

Purpose of the Study:

• To investigate the role of MAO activity and catecholamine metabolism in OA pathogenesis.
• To evaluate the efficacy of diclofenac sodium and tribenoside, individually and in combination, in preventing OA development in STR/ORT mice.

Main Methods:

• Monitoring MAO activity and distribution in male STR/ORT mice.
• Histological assessment of tibial cartilage for OA.
• Pharmacological intervention using diclofenac sodium and tribenoside.

Main Results:

• Diclofenac sodium partially normalized MAO activity but did not yield significant histological improvement.
• Tribenoside addressed extracellular matrix edema, a proposed secondary factor in OA.
• Simultaneous administration of diclofenac sodium and tribenoside resulted in 7 out of 9 mice showing no signs of OA.

Conclusions:

• OA pathogenesis in STR/ORT mice involves both cellular and extracellular factors.
• Combined therapy targeting both factors demonstrated significant potential in preventing OA.
• Further research is warranted to explore this dual-action therapeutic approach for osteoarthritis.